Home » Newsletters » BioWorld Science

BioWorld Science

July 21, 2004

View Archived Issues

Nudix hydrolases show promise as antibiotic targets in tuberculosis

Cel-Sci reviews recent progress

Bavarian Nordic and GlaxoSmithKline in global Imvamune collaboration

First phase III study of GVAX prostate cancer vaccine commences enrollment

Phase II results for INKP-102

Completion of financing round at Acuity

Therapeutic benefits of mitoxantrone in multiple sclerosis

Acamprosate does not affect alcohol pharmacokinetics and pharmacodynamics

Telomerase inhibitor inhibits glioblastoma growth in vivo

LY-411575 tested in novel animal model of Alzheimer's

Novel therapeutic polyagent for Alzheimer's disease therapy

Aeolus name change completed

FDA extends review period for low-dose Yasmin NDA

European approval for Teveten Plus

AOP Orphan obtains Thromboreductin registrations in Central Europe

First phase II monotherapy study of 17-AAG begins

Novavax to reacquire rights to Estrasorb from King

Diversa signs agreement with GSK to advance novel antiinfective

Lower resistance to NNRTIs found with nevirapine plus Combivir in HIV-infected mothers

Low incidence of resistance to PIs found in HIV-infected patients treated with lopinavir/ritonavir

Novel cell penetrating peptides inhibit HIV-1 replication

Promising vitamin D analogue for the treatment of psoriasis

Antiinflammatory effects of PDE4 inhibitors on airways epithelial cell functions

Novel PARP inhibitors for the treatment of cerebral infarction

Sankyo isolates new antibacterial agents

Yamanouchi reports VEGF inhibitors for angiogenesis-related disorders

HIV integrase inhibitors described by Japan Tobacco

ProSkelia claims vitronectin receptor antagonists

Fujisawa discloses selective cyclooxygenase-1 inhibitors

Transdermal lidocaine for the treatment of neuropathic sensory loss

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...